Empowering Health Through Innovative Clinical Diagnostics
Trinity Biotech develops, manufactures, and markets diagnostic systems, including reagents and instrumentation, for point-of-care and clinical laboratories, and has recently entered the wearable biosensor industry. Our products detect a range of conditions, including infectious diseases, sexually transmitted diseases, autoimmune disorders, haemoglobin disorders, and also monitor diabetic markers
Our sales partners in over 100 countries
With a presence on the NASDAQ exchange, Trinity Biotech sells direct in the United States and through a network of international distributors and strategic partners in over 100 countries worldwide. They reach customers globally through a combination of an in-house sales force, international distributors, and strategic partners.
We are dedicated to improving patient care through the development and delivery of innovative diagnostic solutions that enable accurate and timely diagnosis of medical conditions.
Trinity Biotech is dedicated to delivering high-quality products for the diagnostics market. Our US and Irish facilities are FDA and ISO registered, holding certifications such as ISO 13485, MDSAP and CAN/CSA ISO 13485.03 validated by internationally recognised bodies, affirming our adherence to established quality systems.
